Grace Shu Hui Chiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Grace Shu Hui Chiang has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
Boon Yeow Tan
Department of Medicine, St Luke’s Hospital, Singapore
2 shared publications- Eunice Wei Xin Lee
Yong Loo Lin School of Medicine, National University of Singapore, Singapore
2 shared publications Kamun Tong
St Luke's Hospital
2 shared publications- Laureen Yi-Ting Wang
Department of Medicine, Alexandra Hospital, 378 Alexandra Road, Singapore, 159964, Singapore, +65 69082222
2 shared publications - Albert C. Liu
Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill (A.M.K.-N., A.C.L.).
1 shared publication B. Y. Tan
St. Luke’s Hospital
1 shared publication
Latest Publications
- Open Access
- 25 May 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e83574
Evaluating a Preventive Heart Health Program for Women at Midlife: Protocol for a Mixed Methods Pilot Study
Background: Cardiovascular disease (CVD) is the leading cause of death in women. Risk factors can be compounded by hormonal changes, especially during the menopause transition. Positive health promotion through a behavioral change strategy may be the most effective approach to reducing CVD mortality and morbidity. Objective: Health care providers are instrumental in identifying and managing CVD risk factors in women. This study aims to explore and assess the barriers and facilitators to implementing preventive heart health care in Singapore. Methods: A prospective mixed methods pilot study using both quantitative and qualitative research methods for program implementation and evaluation through an interrupted time series study design will be conducted with a sample of 100 women aged 45 to 65 years. An A-B-A reversal design of 6-month intervals (baseline [A]—participants’ healthy heart behaviors before the introduction of health coaching, intervention [B]—health coaching is introduced and participants’ behaviors are measured to observe for changes from baseline, and return to baseline [A]—health coaching is removed and there is a return to baseline) will be used to assess the feasibility and acceptability of behavioral change strategies to increase heart-healthy habits. Data collection will occur over 3 phases: the preimplementation phase, the implementation phase, and the postimplementation phase. Quantitative data collection will include structured surveys. Qualitative interviews will be conducted among a subset of patients and health care providers for the exploratory evaluation of this study. Purposive sampling will be used for the recruitment of interview participants. Primary outcomes will be the reach, effectiveness, adoption, and feasibility of the preventive heart health program. Secondary outcomes will include laboratory blood test results and CVD risk assessment. A segmented regression analysis of interrupted time series will be used to evaluate the impact of the behavioral change strategy intervention. Qualitative data will be analyzed using an inductive approach, and thematic synthesis will be used to identify patterns. Integrating quantitative and qualitative data will facilitate a nuanced understanding of the barriers and facilitators of implementing a preventive heart health program among midlife women. Results: This study was funded in May 2022. Data collection started in April 2024 and is projected to end in April 2026. A total of 60 participants had been enrolled as of December 2025. Data analysis is expected to commence in June 2026 and expected results published in the autumn of 2026. Conclusions: Experiential knowledge arising from the adoption of personalized health coaching for midlife women can help ascertain the contextual challenges and effectiveness of service implementation in Singapore. Study findings can contribute to refining the framework of sex-specific, tailored CVD prevention care; enable upscaling of such services to other hospitals; and improve future preventive care for midlife women.
- 25 May 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e83574
Open AccessEvaluating a Preventive Heart Health Program for Women at Midlife: Protocol for a Mixed Methods Pilot Study
Background: Cardiovascular disease (CVD) is the leading cause of death in women. Risk factors can be compounded by hormonal changes, especially during the menopause transition. Positive health promotion through a behavioral change strategy may be the most effective approach to reducing CVD mortality and morbidity. Objective: Health care providers are instrumental in identifying and managing CVD risk factors in women. This study aims to explore and assess the barriers and facilitators to implementing preventive heart health care in Singapore. Methods: A prospective mixed methods pilot study using both quantitative and qualitative research methods for program implementation and evaluation through an interrupted time series study design will be conducted with a sample of 100 women aged 45 to 65 years. An A-B-A reversal design of 6-month intervals (baseline [A]—participants’ healthy heart behaviors before the introduction of health coaching, intervention [B]—health coaching is introduced and participants’ behaviors are measured to observe for changes from baseline, and return to baseline [A]—health coaching is removed and there is a return to baseline) will be used to assess the feasibility and acceptability of behavioral change strategies to increase heart-healthy habits. Data collection will occur over 3 phases: the preimplementation phase, the implementation phase, and the postimplementation phase. Quantitative data collection will include structured surveys. Qualitative interviews will be conducted among a subset of patients and health care providers for the exploratory evaluation of this study. Purposive sampling will be used for the recruitment of interview participants. Primary outcomes will be the reach, effectiveness, adoption, and feasibility of the preventive heart health program. Secondary outcomes will include laboratory blood test results and CVD risk assessment. A segmented regression analysis of interrupted time series will be used to evaluate the impact of the behavioral change strategy intervention. Qualitative data will be analyzed using an inductive approach, and thematic synthesis will be used to identify patterns. Integrating quantitative and qualitative data will facilitate a nuanced understanding of the barriers and facilitators of implementing a preventive heart health program among midlife women. Results: This study was funded in May 2022. Data collection started in April 2024 and is projected to end in April 2026. A total of 60 participants had been enrolled as of December 2025. Data analysis is expected to commence in June 2026 and expected results published in the autumn of 2026. Conclusions: Experiential knowledge arising from the adoption of personalized health coaching for midlife women can help ascertain the contextual challenges and effectiveness of service implementation in Singapore. Study findings can contribute to refining the framework of sex-specific, tailored CVD prevention care; enable upscaling of such services to other hospitals; and improve future preventive care for midlife women.
- Open Access
- 5 September 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Evaluating A Preventive Heart Health Programme For Women At Midlife: Protocol For An Interrupted Time Series Design (Preprint)
UNSTRUCTURED Cardiovascular disease (CVD) is the leading cause of death in women and the risk factors can be compounded by hormonal changes, especially in menopause transition. Positive health promotion through behavioural change strategy may be the most effective approach to reduce CVD mortality and morbidity. As healthcare providers play a critical role in identifying and managing CVD risk factors in women, this highlights the need to explore and assess the barriers and facilitators to implementing preventive heart health care in Singapore. A prospective mixed-methods study utilising both quantitative and qualitative research methods for programme implementation and evaluation through an interrupted time series (ITS) study design with a focus on behavioural change will be conducted. An A-B-A reversal design will be used to assess the feasibility and acceptability of behavioural change strategy to increase heart-healthy habits. 100 women aged 45-65 years-old will be recruited. Quantitative data regarding participants’ clinical status, symptoms, and self-administered surveys will also be collected. 15 participants and healthcare providers will be engaged for a qualitative semi-structured survey and interview for the exploratory evaluation of this study. This study aims to implement and evaluate the effectiveness of a preventive heart health programme targeted for women with CVD risk factors.
- 5 September 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessEvaluating A Preventive Heart Health Programme For Women At Midlife: Protocol For An Interrupted Time Series Design (Preprint)
UNSTRUCTURED Cardiovascular disease (CVD) is the leading cause of death in women and the risk factors can be compounded by hormonal changes, especially in menopause transition. Positive health promotion through behavioural change strategy may be the most effective approach to reduce CVD mortality and morbidity. As healthcare providers play a critical role in identifying and managing CVD risk factors in women, this highlights the need to explore and assess the barriers and facilitators to implementing preventive heart health care in Singapore. A prospective mixed-methods study utilising both quantitative and qualitative research methods for programme implementation and evaluation through an interrupted time series (ITS) study design with a focus on behavioural change will be conducted. An A-B-A reversal design will be used to assess the feasibility and acceptability of behavioural change strategy to increase heart-healthy habits. 100 women aged 45-65 years-old will be recruited. Quantitative data regarding participants’ clinical status, symptoms, and self-administered surveys will also be collected. 15 participants and healthcare providers will be engaged for a qualitative semi-structured survey and interview for the exploratory evaluation of this study. This study aims to implement and evaluate the effectiveness of a preventive heart health programme targeted for women with CVD risk factors.
- Open Access
- 3 January 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (1) , 364
Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits
This review describes our current understanding of the role of the mitochondria in the repurposing of the anti-diabetes drugs metformin, gliclazide, GLP-1 receptor agonists, and SGLT2 inhibitors for additional clinical benefits regarding unhealthy aging, long COVID, mental neurogenerative disorders, and obesity. Metformin, the most prominent of these diabetes drugs, has been called the “Drug of Miracles and Wonders,” as clinical trials have found it to be beneficial for human patients suffering from these maladies. To promote viral replication in all infected human cells, SARS-CoV-2 stimulates the infected liver cells to produce glucose and to export it into the blood stream, which can cause diabetes in long COVID patients, and metformin, which reduces the levels of glucose in the blood, was shown to cut the incidence rate of long COVID in half for all patients recovering from SARS-CoV-2. Metformin leads to the phosphorylation of the AMP-activated protein kinase AMPK, which accelerates the import of glucose into cells via the glucose transporter GLUT4 and switches the cells to the starvation mode, counteracting the virus. Diabetes drugs also stimulate the unfolded protein response and thus mitophagy, which is beneficial for healthy aging and mental health. Diabetes drugs were also found to mimic exercise and help to reduce body weight.
- 3 January 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (1) , 364
Open AccessMitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits
This review describes our current understanding of the role of the mitochondria in the repurposing of the anti-diabetes drugs metformin, gliclazide, GLP-1 receptor agonists, and SGLT2 inhibitors for additional clinical benefits regarding unhealthy aging, long COVID, mental neurogenerative disorders, and obesity. Metformin, the most prominent of these diabetes drugs, has been called the “Drug of Miracles and Wonders,” as clinical trials have found it to be beneficial for human patients suffering from these maladies. To promote viral replication in all infected human cells, SARS-CoV-2 stimulates the infected liver cells to produce glucose and to export it into the blood stream, which can cause diabetes in long COVID patients, and metformin, which reduces the levels of glucose in the blood, was shown to cut the incidence rate of long COVID in half for all patients recovering from SARS-CoV-2. Metformin leads to the phosphorylation of the AMP-activated protein kinase AMPK, which accelerates the import of glucose into cells via the glucose transporter GLUT4 and switches the cells to the starvation mode, counteracting the virus. Diabetes drugs also stimulate the unfolded protein response and thus mitophagy, which is beneficial for healthy aging and mental health. Diabetes drugs were also found to mimic exercise and help to reduce body weight.
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S23)
Baseline Frailty and Domain‐specific Cognitive Declines in Healthy and MCI Older Adults
Background: Both physical frailty and cognitive decline increase with age and each place adults at elevated risk for loss of independence. Inconsistent associations have been found between frailty and risk for cognitive declines across cognitive domains. However, most studies were cross‐sectional and did not include a comprehensive battery of neuropsychological tests. We hypothesized that frail older adults, whether with or without Mild Cognitive Impairment (MCI) at baseline, are at risk for accelerated domain‐specific cognitive declines.Method: The Ginkgo Evaluation of Memory Study (GEMS) was a prospective study of 3069 dementia‐free older adults aged 72‐96 years, followed for up to 7.5 years or a diagnosis of dementia, 482 of whom were diagnosed with MCI at baseline. A modified physical frailty phenotype was constructed using GEMS baseline data. A Neuropsychological Battery consisted of 13 tests reflecting global cognition, memory, visual‐spatial construction, language, psychomotor speed/attention, and executive function were administered annually. Linear random effects models were used to compare differences in baseline and rate of change in domain scores among individuals with and without baseline frailty.Result: Overall, frail participants showed poorer baseline cognitive function in all domains, and greater declines in all cognitive domains. When stratified by baseline MCI, among non‐MCI participants, those with frailty revealed poorer baseline psychomotor speed/attention and executive function, and greater declines in all cognitive domains. Among MCI participants, those with frailty exhibited lower baseline visual‐spatial construction, and greater declines in all cognitive domains except for visual‐spatial construction and executive function. In all cognitive domains, the estimated effect of frailty on cognitive decline was greater in MCI participants than non‐MCI participants.Conclusion: Frailty was predictive of accelerated cognitive declines across domains and more so in those with baseline MCI. The results from this study highlight the importance of assessing frailty as a risk factor for accelerated cognitive declines, particularly among those at elevated preclinical cognitive risk. These individuals may be at the greatest risk of transitioning to dementia.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S23)
Open AccessBaseline Frailty and Domain‐specific Cognitive Declines in Healthy and MCI Older Adults
Background: Both physical frailty and cognitive decline increase with age and each place adults at elevated risk for loss of independence. Inconsistent associations have been found between frailty and risk for cognitive declines across cognitive domains. However, most studies were cross‐sectional and did not include a comprehensive battery of neuropsychological tests. We hypothesized that frail older adults, whether with or without Mild Cognitive Impairment (MCI) at baseline, are at risk for accelerated domain‐specific cognitive declines.Method: The Ginkgo Evaluation of Memory Study (GEMS) was a prospective study of 3069 dementia‐free older adults aged 72‐96 years, followed for up to 7.5 years or a diagnosis of dementia, 482 of whom were diagnosed with MCI at baseline. A modified physical frailty phenotype was constructed using GEMS baseline data. A Neuropsychological Battery consisted of 13 tests reflecting global cognition, memory, visual‐spatial construction, language, psychomotor speed/attention, and executive function were administered annually. Linear random effects models were used to compare differences in baseline and rate of change in domain scores among individuals with and without baseline frailty.Result: Overall, frail participants showed poorer baseline cognitive function in all domains, and greater declines in all cognitive domains. When stratified by baseline MCI, among non‐MCI participants, those with frailty revealed poorer baseline psychomotor speed/attention and executive function, and greater declines in all cognitive domains. Among MCI participants, those with frailty exhibited lower baseline visual‐spatial construction, and greater declines in all cognitive domains except for visual‐spatial construction and executive function. In all cognitive domains, the estimated effect of frailty on cognitive decline was greater in MCI participants than non‐MCI participants.Conclusion: Frailty was predictive of accelerated cognitive declines across domains and more so in those with baseline MCI. The results from this study highlight the importance of assessing frailty as a risk factor for accelerated cognitive declines, particularly among those at elevated preclinical cognitive risk. These individuals may be at the greatest risk of transitioning to dementia.
- Open Access
- 24 October 2021
- Published by Medknow in Singapore Medical Journal
- Vol. 65 (2) , 123-128
Prevalence of risk of distress and associated factors among physicians, nurses and rehabilitation therapists in a community hospital: a cross-sectional study
- 24 October 2021
- Published by Medknow in Singapore Medical Journal
- Vol. 65 (2) , 123-128
Open AccessPrevalence of risk of distress and associated factors among physicians, nurses and rehabilitation therapists in a community hospital: a cross-sectional study
- 20 August 2020
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 36 (1) , 62-68
Primary Care Prognostic (PCP) Index of 11-Year Mortality Risk: Development and Validation of a Brief Prognostic Tool
Background Healthcare providers use a life expectancy of at least 5 to 10 years in shared clinical decision-making with older adults about cancer screening, major surgeries, and disease prevention interventions. At present, few prognostic indexes predict long-term mortality beyond 10 years or are suited for use in primary care settings. Objective We developed and validated an 8-item multidimensional index predicting 11-year mortality for use in primary care. Design, Setting, and Participants Using data from the Singapore Longitudinal Ageing Studies (SLAS), we developed a Primary Care Prognostic (PCP) Index for predicting 11-year mortality risk in a development cohort (n = 1550) and validated it in a geographically different cohort (n = 928). Main Measures The PCP Index was derived from eight indicators (body mass loss, weakness, slow gait, comorbidity, polypharmacy, IADL/BADL dependency, low albumin, low total cholesterol, out of 25 candidate indicators) using stepwise Cox proportional hazard models. Key Results In the developmental cohort, the mortality hazard ratio increased by 53% per PCP point score increase, independent of age and sex. Across risk categories, absolute risks of mortality increased from 5% (score 0) to 67.9% (scores 7–9), with area under curve (AUC = 0.77 (95% CI 0.73–0.80)). The PCP Index also predicted mortality in the validation cohort, with AUC = 0.70 (95% CI 0.64–0.75). Conclusions The PCP Index using simple clinical assessments and point scoring is a potentially useful prognostic tool for predicting long-term mortality and is well suited for risk stratification and shared clinical decision-making with older adults in primary care.
- 20 August 2020
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 36 (1) , 62-68
Primary Care Prognostic (PCP) Index of 11-Year Mortality Risk: Development and Validation of a Brief Prognostic Tool
Background Healthcare providers use a life expectancy of at least 5 to 10 years in shared clinical decision-making with older adults about cancer screening, major surgeries, and disease prevention interventions. At present, few prognostic indexes predict long-term mortality beyond 10 years or are suited for use in primary care settings. Objective We developed and validated an 8-item multidimensional index predicting 11-year mortality for use in primary care. Design, Setting, and Participants Using data from the Singapore Longitudinal Ageing Studies (SLAS), we developed a Primary Care Prognostic (PCP) Index for predicting 11-year mortality risk in a development cohort (n = 1550) and validated it in a geographically different cohort (n = 928). Main Measures The PCP Index was derived from eight indicators (body mass loss, weakness, slow gait, comorbidity, polypharmacy, IADL/BADL dependency, low albumin, low total cholesterol, out of 25 candidate indicators) using stepwise Cox proportional hazard models. Key Results In the developmental cohort, the mortality hazard ratio increased by 53% per PCP point score increase, independent of age and sex. Across risk categories, absolute risks of mortality increased from 5% (score 0) to 67.9% (scores 7–9), with area under curve (AUC = 0.77 (95% CI 0.73–0.80)). The PCP Index also predicted mortality in the validation cohort, with AUC = 0.70 (95% CI 0.64–0.75). Conclusions The PCP Index using simple clinical assessments and point scoring is a potentially useful prognostic tool for predicting long-term mortality and is well suited for risk stratification and shared clinical decision-making with older adults in primary care.
- Open Access
- 1 June 2018
- Published by Hong Kong Baptist University in Asian Journal of the Scholarship of Teaching and Learning
- Vol. 8 (1) , 111-132
Importance and Impact of a Longitudinal Ethics, Law and Professionalism Curriculum on Medical Students' Knowledge and Professional Attitudes
Introduction With an ageing population and rising complexity of care, helping medical students to develop an ethically, legally, and professionally sound approach to clinical practice is becoming even more important. This cross-sectional study explores how medical students’ knowledge and application of ethical principles and professional attitudes develop during a longitudinal programme in health ethics, law and professionalism. Our research aims to evaluate the impact of longitudinal medical ethics curriculum on medical students’ knowledge of ethical principles and professional attitudes as they transition from pre-clinical to clinical years. Methods Anonymised self-reported questionnaires assessing ethical knowledge and decision-making were administered to two groups of medical students in 2015 and 2016—preclinical year students [Year 2 (n=162)] and clinical year students [Year 5 (n=167)]. The study focused on Years 2 and 5 students as our aim was to evaluate how their perspectives differed after the end of both the pre-clinical and clinical years. Information on demographics were also collected. Results As expected, more Year 5 as compared to Year 2 students had a positive attitude and confidence towards medical ethics and decision-making. Although Year 2 students had limited patient exposure, their knowledge of key medical ethics principles was comparable to the Year 5 graduating medical students. However, there was variance between pre-clinical and clinical students’ normative assessment of factors and practices in clinical ethical decision[1]making in scenarios such as resuscitation, disclosure of avoidable errors, truth concealment, and euthanasia. Discussion Medical ethics teaching has a positive impact on knowledge but strategies should be implemented to mitigate the effects of clinical exposure and to ensure more uniformity in normative assessment. Conclusion Longitudinal programme in health ethics, law and professionalism did enhance knowledge and professional attitudes in both preclinical and clinical year students. There was evidence of ethical erosion in a few of the domains for students in clinical years.
- 1 June 2018
- Published by Hong Kong Baptist University in Asian Journal of the Scholarship of Teaching and Learning
- Vol. 8 (1) , 111-132
Open AccessImportance and Impact of a Longitudinal Ethics, Law and Professionalism Curriculum on Medical Students' Knowledge and Professional Attitudes
Introduction With an ageing population and rising complexity of care, helping medical students to develop an ethically, legally, and professionally sound approach to clinical practice is becoming even more important. This cross-sectional study explores how medical students’ knowledge and application of ethical principles and professional attitudes develop during a longitudinal programme in health ethics, law and professionalism. Our research aims to evaluate the impact of longitudinal medical ethics curriculum on medical students’ knowledge of ethical principles and professional attitudes as they transition from pre-clinical to clinical years. Methods Anonymised self-reported questionnaires assessing ethical knowledge and decision-making were administered to two groups of medical students in 2015 and 2016—preclinical year students [Year 2 (n=162)] and clinical year students [Year 5 (n=167)]. The study focused on Years 2 and 5 students as our aim was to evaluate how their perspectives differed after the end of both the pre-clinical and clinical years. Information on demographics were also collected. Results As expected, more Year 5 as compared to Year 2 students had a positive attitude and confidence towards medical ethics and decision-making. Although Year 2 students had limited patient exposure, their knowledge of key medical ethics principles was comparable to the Year 5 graduating medical students. However, there was variance between pre-clinical and clinical students’ normative assessment of factors and practices in clinical ethical decision[1]making in scenarios such as resuscitation, disclosure of avoidable errors, truth concealment, and euthanasia. Discussion Medical ethics teaching has a positive impact on knowledge but strategies should be implemented to mitigate the effects of clinical exposure and to ensure more uniformity in normative assessment. Conclusion Longitudinal programme in health ethics, law and professionalism did enhance knowledge and professional attitudes in both preclinical and clinical year students. There was evidence of ethical erosion in a few of the domains for students in clinical years.
- Open Access
- 27 March 2018
- Published by Cambridge University Press (CUP) in Primary Health Care Research & Development
- Vol. 19 (6) , 610-615
Determinants of poor sleep quality in elderly patients with diabetes mellitus, hyperlipidemia and hypertension in Singapore
Aim: The objective of this study was to assess determinants of poor sleep quality which is an under-diagnosed and under-treated problem in elderly patients with diabetes mellitus, hyperlipidemia and hypertension.Background: Poor sleep quality is linked to decreased quality of life, increased morbidity and mortality. Poor sleep quality is common in the elderly population with associated cardiometabolic risk factors such as diabetes, hyperlipidemia and hypertension.Methods: This is a cross-sectional study undertaken in the primary healthcare setting (Singhealth Polyclinics-Outram) in Singapore. Singaporeans aged 65 years and above who had at least one of the three cardiometabolic risk factors (diabetes, hypertension and hyperlipidemia) were identified. Responders’ sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI) questionnaire and were divided into those with good quality sleep and those with poor quality sleep, based on the PSQI score. Information on demographics, co-morbidities and lifestyle practices were collected. Descriptive and multivariate analyses of determinants of poor sleep were determined.Findings: There were 199 responders (response rate 88.1%). Nocturia (adjusted prevalence rate ratio 1.54, 95% confidence interval 1.06–2.26) was found to be associated with an increased risk of poor sleep quality in elderly patients with diabetes mellitus, hypertension and hyperlipidaemia. Nocturia, a prevalent problem in the Asian elderly population, has been found to be associated with poor sleep quality in our study. Hence, it is imperative to identify and treat patients with nocturia to improve sleep quality among them.
- 27 March 2018
- Published by Cambridge University Press (CUP) in Primary Health Care Research & Development
- Vol. 19 (6) , 610-615
Open AccessDeterminants of poor sleep quality in elderly patients with diabetes mellitus, hyperlipidemia and hypertension in Singapore
Aim: The objective of this study was to assess determinants of poor sleep quality which is an under-diagnosed and under-treated problem in elderly patients with diabetes mellitus, hyperlipidemia and hypertension.Background: Poor sleep quality is linked to decreased quality of life, increased morbidity and mortality. Poor sleep quality is common in the elderly population with associated cardiometabolic risk factors such as diabetes, hyperlipidemia and hypertension.Methods: This is a cross-sectional study undertaken in the primary healthcare setting (Singhealth Polyclinics-Outram) in Singapore. Singaporeans aged 65 years and above who had at least one of the three cardiometabolic risk factors (diabetes, hypertension and hyperlipidemia) were identified. Responders’ sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI) questionnaire and were divided into those with good quality sleep and those with poor quality sleep, based on the PSQI score. Information on demographics, co-morbidities and lifestyle practices were collected. Descriptive and multivariate analyses of determinants of poor sleep were determined.Findings: There were 199 responders (response rate 88.1%). Nocturia (adjusted prevalence rate ratio 1.54, 95% confidence interval 1.06–2.26) was found to be associated with an increased risk of poor sleep quality in elderly patients with diabetes mellitus, hypertension and hyperlipidaemia. Nocturia, a prevalent problem in the Asian elderly population, has been found to be associated with poor sleep quality in our study. Hence, it is imperative to identify and treat patients with nocturia to improve sleep quality among them.
- 1 April 2017
- Vol. 63 (4) , 288-291
Olfactory groove and planum sphenoidale meningioma: Dementia masquerade.
- 1 April 2017
- Vol. 63 (4) , 288-291
Olfactory groove and planum sphenoidale meningioma: Dementia masquerade.
- 21 November 2014
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 62 (11) , 2221-2222
Acupuncture Causing Methicillin‐Sensitive Staphylococcus aureus Spondylodiscitis Resulting in Bacteremia and Bacteriuria
- 21 November 2014
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 62 (11) , 2221-2222
Acupuncture Causing Methicillin‐Sensitive Staphylococcus aureus Spondylodiscitis Resulting in Bacteremia and Bacteriuria